Your browser doesn't support javascript.
loading
Development of additional pituitary hormone deficiencies in pediatric patients originally diagnosed with isolated growth hormone deficiency due to organic causes.
Child, Christopher J; Blum, Werner F; Deal, Cheri; Zimmermann, Alan G; Quigley, Charmian A; Drop, Stenvert L S; Cutler, Gordon B; Rosenfeld, Ron G.
Afiliação
  • Child CJ; Lilly Research LaboratoriesErl Wood Manor, Windlesham, Surrey, UK cjc@lilly.com.
  • Blum WF; University of GiessenGiessen, Germany.
  • Deal C; University of Montreal and CHU Ste-JustineMontreal, Quebec, Canada.
  • Zimmermann AG; Lilly Research LaboratoriesIndianapolis, Indiana, USA.
  • Quigley CA; Sydney Children's HospitalRandwick, New South Wales, Australia.
  • Drop SL; Department of PediatricsErasmus Medical Centre, Sophia Children's Hospital, Rotterdam, The Netherlands.
  • Cutler GB; Gordon Cutler Consultancy LLCDeltaville, Virginia, USA.
  • Rosenfeld RG; Department of PediatricsOregon Health and Science University, Portland, Oregon, USA.
Eur J Endocrinol ; 174(5): 669-79, 2016 May.
Article em En | MEDLINE | ID: mdl-26888628
OBJECTIVE: To determine characteristics of children initially diagnosed with isolated growth hormone deficiency (IGHD) of organic aetiology, who later developed multiple pituitary hormone deficiencies (MPHD). DESIGN: Data were analysed for 716 growth hormone-treated children with organic IGHD, who were growth hormone-naïve at baseline in the multinational, observational Genetics and Neuroendocrinology of Short Stature International Study. METHODS: Development of MPHD was ascertained from investigator-provided diagnoses, adverse events and concomitant medications. Analyses were performed for all patients and separately for those who developed MPHD within 4.5 years or had >3.5 years follow-up and continued to have IGHD (4-year cohort). RESULTS: MPHD developed in 71/716 (9.9%) children overall, and in 60/290 (20.7%) in the 4-year cohort. The most frequent additional deficiencies were thyroid-stimulating hormone (47 patients) and gonadotropins (23 patients). Compared with those who remained with IGHD, children who developed MPHD had more severe GHD at study entry, significantly lower baseline insulin-like growth factor1, peak stimulated growth hormone, and more frequent diagnosis of intracranial tumour or mutation of gene(s) controlling hypothalamic-pituitary development and/or function. Multivariate logistic regression analyses identified female gender, longer follow-up, higher baseline age and lower peak stimulated growth hormone as predictors of MPHD development. CONCLUSIONS: MPHD is more likely to develop in patients with severe organic IGHD, especially those with history of intracranial tumour or mutation of gene(s) controlling hypothalamic-pituitary development and/or function. Older baseline age, female gender and longer follow-up duration were also associated with higher incidence of MPHD. Long-term monitoring of pituitary function is recommended, irrespective of the aetiology of GHD.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hormônios Hipofisários / Progressão da Doença / Hormônio do Crescimento Humano / Gonadotropinas / Hipopituitarismo Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Child / Female / Humans / Male Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hormônios Hipofisários / Progressão da Doença / Hormônio do Crescimento Humano / Gonadotropinas / Hipopituitarismo Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Child / Female / Humans / Male Idioma: En Ano de publicação: 2016 Tipo de documento: Article